Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 7NIH 2INDUSTRY 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma 14Sarcoma 13Lymphoma, Large B-Cell, Diffuse 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Leukemia 9Burkitt Lymphoma 7Lymphoma, Mantle-Cell 6Lymphoma, Follicular 6Lung Neoplasms 6Neuroectodermal Tumors, Primitive, Peripheral 5Lymphoma, Non-Hodgkin 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large-Cell, Anaplastic 5Lymphoma, B-Cell, Marginal Zone 5Liposarcoma 5Leukemia, Lymphocytic, Chronic, B-Cell 5Fibrosarcoma 5Neuroblastoma 4Hodgkin Disease 4Hemangiosarcoma 4Carcinoma, Non-Small-Cell Lung 4Testicular Neoplasms 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Neoplasms 3Malignant mesenchymal tumor 3Leukemia, Myeloid, Acute 3Hemangiopericytoma, Malignant 3Dendritic Cell Sarcoma, Interdigitating 3Central Nervous System Neoplasms 3Blast Crisis 3

Interventions

Peripheral Blood Stem Cell Transplantation 5fludarabine phosphate 4Radiotherapy 4Antilymphocyte Serum 4Vincristine 3Vinblastine 3Procarbazine 3Prednisolone 3Methylprednisolone 3Melphalan 3Filgrastim 3Doxorubicin 3Cyclophosphamide 3Chlorambucil 3Busulfan 3Bortezomib 3Bevacizumab 3tipifarnib 2Vorinostat 2Sorafenib 2Oxaliplatin 2Mycophenolic Acid 2Methotrexate 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Dacarbazine 2Cyclosporine 2Bleomycin 2Biopsy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Recurrence × Ifosfamide × Clear all
NCT00381940 2021-03-24

Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy

National Cancer Institute (NCI)

Phase 2 Completed
26 enrolled 14 charts
Lymphoid

Hodgkin Disease, Recurrence

NCT00025064 2013-08-07

Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 2 Unknown
260 enrolled
Lymphoid

Lymphoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡